stockrow
Friday 6 November 2026
Export ZBH’s income statement to Excel — free account
Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
105.28
1.57
−1.47%
Follow ZBH
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
25.19 | 23.74 | 24.72 | 115.71 | 64.57 | 0.00 | 26.65 | 0.00 | 13.37 | 68.03 |
Piotroski F-Score |
6 | 6 | 8 | 5 | 7 | 3 | 7 | 5 | 6 | 5 |
P/S ratio |
2.16 | 2.79 | 3.43 | 3.84 | 3.81 | 5.11 | 3.77 | 2.61 | 3.15 | 2.64 |
Altman Z-Score |
2.38 | 2.86 | 3.01 | 2.97 | 2.54 | 2.50 | 2.61 | 1.95 | 2.01 | 1.65 |
Altman Z″-Score (non-manufacturers) |
3.96 | 4.25 | 3.96 | 3.74 | 3.31 | 3.10 | 3.09 | 2.76 | 2.70 | 2.40 |
P/FCF ratio |
16.53 | 27.41 | 28.94 | 30.60 | 26.57 | 61.75 | 37.14 | 15.83 | 22.56 | 18.40 |
Beneish M-Score |
(2.59) | (2.59) | (2.54) | (2.62) | (2.72) | (2.57) | (2.43) | (3.07) | (2.51) | (2.59) |
P/Operating CF |
34.41 | 42.37 | 43.06 | 109.25 | 77.00 | 105.64 | 71.14 | 54.56 | 60.99 | 32.32 |
Dividend Safety Score |
72 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.40 | 1.72 | 2.03 | 2.22 | 2.05 | 2.56 | 2.43 | 1.84 | 2.09 | 2.10 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.00 | 3.53 | 4.15 | 4.61 | 4.79 | 6.30 | 4.73 | 3.67 | 4.38 | 4.03 |
EV/EBITDA |
11.28 | 11.89 | 13.76 | 16.71 | 18.02 | 26.01 | 17.04 | 14.17 | 15.59 | 16.33 |
EV/Operating CF |
14.57 | 18.10 | 19.40 | 23.59 | 23.28 | 35.90 | 23.79 | 16.65 | 21.61 | 18.92 |
EV/FCF |
22.96 | 34.67 | 35.05 | 36.70 | 33.41 | 76.21 | 46.51 | 22.24 | 31.39 | 28.02 |
Quick Ratio |
0.89 | 0.82 | 0.65 | 0.75 | 0.47 | 0.88 | 0.58 | 0.75 | 0.67 | 0.94 |
Current Ratio |
1.98 | 1.91 | 1.61 | 1.88 | 1.41 | 1.99 | 1.37 | 1.83 | 1.49 | 1.96 |
Net Debt/EBITDA |
3.16 | 2.49 | 2.40 | 2.78 | 3.69 | 4.93 | 3.43 | 4.09 | 4.38 | 5.61 |
Debt/Assets |
32.56% | 29.04% | 26.83% | 27.04% | 30.14% | 33.28% | 33.37% | 37.05% | 38.99% | 42.13% |
Debt/Equity |
0.59 | 0.50 | 0.46 | 0.47 | 0.56 | 0.67 | 0.66 | 0.79 | 0.86 | 1.16 |
Asset Turnover |
0.37 | 0.36 | 0.35 | 0.31 | 0.29 | 0.25 | 0.33 | 0.32 | 0.30 | 0.28 |
Operating CF/Net income |
2.41 | 1.66 | 1.54 | 5.86 | 3.50 | (7.74) | 1.40 | (4.61) | 0.87 | 5.34 |
Capex/Depreciation |
(0.53) | (0.60) | (0.74) | (0.39) | (0.45) | (0.26) | (0.67) | (0.22) | (0.35) | (0.50) |
Interest Coverage |
3.75 | 5.90 | 6.35 | 4.23 | 4.13 | 0.39 | 5.01 | 0.12 | 2.46 | 2.31 |
| 5.60% | 7.24% | 8.35% | 1.87% | 3.23% | (1.13%) | 9.56% | (3.30%) | 16.95% | 3.13% | |
| 3.17% | 4.22% | 4.81% | 1.04% | 1.68% | (0.57%) | 4.64% | (1.51%) | 6.88% | 1.14% | |
ROIC |
3.50% | 4.43% | 4.48% | 2.51% | 2.78% | 0.27% | 3.56% | 0.11% | 2.34% | 2.53% |
Return on Tangible Assets |
14.87% | 21.17% | 26.86% | 5.87% | 12.34% | (3.04%) | 33.68% | (9.43%) | 51.33% | 7.08% |
Average Days of Receivables |
75.58 | 70.38 | 71.20 | 72.66 | 67.34 | 86.53 | 62.37 | 58.70 | 72.23 | 76.37 |
Research and Development Expense of Revenue |
5.57% | 5.70% | 6.20% | 5.85% | 6.38% | 5.27% | 5.63% | 4.94% | 4.74% | 4.77% |
Selling, General and Administrative Expense of Revenue |
39.57% | 38.16% | 38.39% | 39.79% | 41.65% | 44.27% | 41.89% | 42.60% | 39.79% | 38.40% |
Intangible Assets out of Total Assets |
0.64 | 0.63 | 0.64 | 0.65 | 0.62 | 0.67 | 0.68 | 0.72 | 0.73 | 0.73 |
Share Based Compensation of Revenue |
1.10% | 1.32% | 1.35% | 1.51% | 1.11% | 1.20% | 1.06% | 0.83% | 0.69% | 0.75% |
Graham Net Nets |
(0.30) | (0.20) | (0.17) | (0.17) | (0.23) | (0.23) | (0.25) | (0.41) | (0.40) | (0.61) |
Graham Number |
71.79 | 78.43 | 81.31 | 37.69 | 51.35 | 0.00 | 86.55 | 0.00 | 109.09 | 40.26 |
Earnings Yield |
3.97% | 4.21% | 4.04% | 0.86% | 1.55% | (0.45%) | 3.75% | (1.82%) | 7.48% | 1.47% |
Free Cash Flow Yield |
6.05% | 3.65% | 3.46% | 3.27% | 3.76% | 1.62% | 2.69% | 6.32% | 4.43% | 5.44% |
Revenue per Share |
41.57 | 37.81 | 35.43 | 33.11 | 32.73 | 29.60 | 38.92 | 38.98 | 38.65 | 38.34 |
Operating CF per Share |
8.57 | 7.38 | 7.58 | 6.47 | 6.73 | 5.20 | 7.73 | 8.59 | 7.84 | 8.16 |
Capex per Share |
(2.92) | (2.94) | (3.38) | (2.27) | (2.04) | (1.79) | (3.51) | (2.16) | (2.44) | (2.65) |
Free Cash Flow per Share |
5.66 | 4.44 | 4.19 | 4.20 | 4.69 | 3.40 | 4.22 | 6.43 | 5.40 | 5.51 |
Cash per Share |
2.99 | 2.59 | 1.99 | 1.79 | 1.81 | 3.87 | 3.01 | 2.67 | 2.60 | 3.17 |
Shareholders Equity per Share |
64.17 | 61.43 | 59.84 | 57.38 | 60.72 | 58.93 | 60.42 | 55.41 | 58.13 | 48.35 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
64.17 | 61.43 | 59.84 | 57.38 | 60.72 | 58.93 | 60.42 | 55.41 | 58.13 | 48.35 |
Free Cash Flow |
1,119.70 | 902.30 | 875.40 | 880.30 | 978.70 | 704.30 | 865.20 | 1,308.40 | 1,089.30 | 1,102.00 |
Working Capital |
2,536.20 | 2,220.60 | 1,752.10 | 2,069.10 | 1,417.10 | 2,526.40 | 1,282.40 | 2,006.10 | 1,495.10 | 2,282.10 |
Capital Expenditures |
(577.40) | (597.10) | (706.20) | (475.90) | (425.60) | (371.30) | (720.60) | (439.00) | (493.00) | (530.20) |
Net Current Asset Value |
(5,266.10) | (4,217.60) | (4,399.20) | (4,611.70) | (5,905.00) | (7,135.00) | (7,522.00) | (8,423.30) | (9,713.70) | (12,350.90) |
EV/EBIT |
22.52 | 21.10 | 24.02 | 45.96 | 37.99 | 464.67 | 33.16 | 861.01 | 42.77 | 37.61 |
Capex to Sales |
0.07 | 0.08 | 0.10 | 0.07 | 0.06 | 0.06 | 0.09 | 0.06 | 0.06 | 0.07 |
Price to Operating Income |
16.21 | 16.69 | 19.83 | 38.31 | 30.22 | 376.54 | 26.47 | 612.61 | 30.74 | 24.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.50 | 0.49 | 0.46 | 0.65 | 0.52 | 0.68 | 0.52 | 1.00 | 0.68 | 0.53 |
Cash ROIC |
5.38% | 4.70% | 4.69% | 4.86% | 4.87% | 3.33% | 4.07% | 6.30% | 4.86% | 5.11% |
Accounts Receivable Turnover |
5.17 | 5.25 | 5.24 | 5.26 | 5.03 | 4.35 | 6.05 | 5.63 | 4.96 | 5.03 |
Accounts Payable Turnover |
10.02 | 7.24 | 5.45 | 6.11 | 6.16 | 4.99 | 5.90 | 6.56 | 6.14 | 7.34 |
Inventory Turnover |
1.10 | 0.95 | 0.92 | 0.94 | 0.85 | 0.75 | 0.97 | 1.05 | 1.06 | 1.13 |
Average Days of Payables |
44.35 | 32.42 | 71.92 | 64.00 | 57.07 | 66.03 | 64.96 | 58.25 | 56.51 | 55.86 |
Days of Inventory on Hand |
334.66 | 372.35 | 417.79 | 388.08 | 399.93 | 490.33 | 386.45 | 362.53 | 353.95 | 300.27 |
Average Receivables |
1,592.55 | 1,461.55 | 1,411.95 | 1,320.55 | 1,356.15 | 1,408.30 | 1,319.85 | 1,409.95 | 1,574.25 | 1,525.45 |
Average Payables |
248.80 | 302.60 | 382.35 | 330.30 | 318.25 | 365.45 | 381.75 | 346.40 | 347.35 | 324.65 |
Average Inventory |
2,260.85 | 2,310.25 | 2,266.20 | 2,147.60 | 2,299.35 | 2,417.85 | 2,320.75 | 2,162.40 | 2,013.85 | 2,106.75 |
Average Assets |
22,228.50 | 21,431.10 | 21,281.45 | 22,261.20 | 23,937.05 | 24,528.20 | 24,382.75 | 25,070.40 | 26,349.20 | 26,922.50 |
Average Common Equity |
12,591.00 | 12,482.20 | 12,257.60 | 12,346.70 | 12,432.90 | 12,296.10 | 11,834.45 | 11,505.80 | 10,702.70 | 9,779.65 |
Columns are period end dates · fundamentals updated 5 Nov 2026